Workflow
icon
搜索文档
UBS Trims Qualcomm’s Target to $150: Why Rising Memory Prices Are Becoming a Chip Stock Headwind
Yahoo Finance· 2026-04-21 22:16
The Analyst's Case UBS sees rising memory prices as a key pressure point for Qualcomm. As memory costs climb, handset manufacturers face margin pressure, which dampens demand for the application processors and modem chips Qualcomm supplies. Qualcomm flagged this dynamic in its most recent earnings report, noting that guidance reflects "the estimated impact of memory supply constraints and related pricing on demand from several handset customers." UBS's concern is that the reset investors hoped for hasn't ma ...
UBS Trims Qualcomm's Target to $150: Why Rising Memory Prices Are Becoming a Chip Stock Headwind
247Wallst· 2026-04-21 22:16
Qualcomm (NASDAQ:QCOM | QCOM Price Prediction) stock is facing renewed pressure after UBS trimmed its price target on the chipmaker, citing deteriorating fundamentals and a new headwind rippling across the semiconductor sector: rising memory prices. ...
Exploring Analyst Estimates for CACI International (CACI) Q3 Earnings, Beyond Revenue and EPS
ZACKS· 2026-04-21 22:16
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. The upcoming report from CACI International (CACI) is expected to reveal quarterly earnings of $6.90 per share, indicating an increase of 10.8% compared to the year-ago period. Analysts forecast revenues of $2.35 billion, representing an increase of 8.3% year over year. Over the last 30 days, there has be ...
Ahead of SouthState (SSB) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2026-04-21 22:16
That said, let's delve into the average estimates of some SouthState metrics that Wall Street analysts commonly model and monitor. Analysts' assessment points toward 'Efficiency Ratio' reaching 53.0%. Compared to the present estimate, the company reported 61.0% in the same quarter last year. It is projected by analysts that the 'Net Interest Margin (Non-Tax Equivalent)' will reach 3.8%. Compared to the present estimate, the company reported 3.8% in the same quarter last year. Analysts forecast 'Average Bala ...
Kinder Morgan (KMI) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2026-04-21 22:16
That said, let's delve into the average estimates of some Kinder Morgan metrics that Wall Street analysts commonly model and monitor. The collective assessment of analysts points to an estimated 'Realized weighted average oil price' of 65 dollars per barrel. The estimate compares to the year-ago value of 68 dollars per barrel. Analysts on Wall Street project that Kinder Morgan (KMI) will announce quarterly earnings of $0.38 per share in its forthcoming report, representing an increase of 11.8% year over yea ...
Unveiling First Citizens (FCNCA) Q1 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2026-04-21 22:16
The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studi ...
Countdown to Snap-On (SNA) Q1 Earnings: Wall Street Forecasts for Key Metrics
ZACKS· 2026-04-21 22:16
Wall Street analysts expect Snap-On (SNA) to post quarterly earnings of $4.68 per share in its upcoming report, which indicates a year-over-year increase of 3.8%. Revenues are expected to be $1.18 billion, up 3.2% from the year-ago quarter. Based on the collective assessment of analysts, 'Net Sales- Financial Services Revenue' should arrive at $103.17 million. The estimate points to a change of +1.1% from the year-ago quarter. Analysts' assessment points toward 'Net Sales- Repair Systems & Information Group ...
Gold Price Analysis – Gold Continues to Sit Near $4800
FX Empire· 2026-04-21 22:16
Geopolitical Factors and Price Targets We are just sitting around waiting to see what happens with the process in the Middle East and whether or not the Americans and the Iranians can finally come to some type of agreement. It is interesting that the ceasefire continues despite the fact that the United States seized an Iranian tanker over the weekend. That being said, the fact that Iran has not gone out of its way to attack anything of substance is a sign that perhaps we are getting closer to the end. If th ...
Cinco de Mayo and Taco Tuesday Fall on the Same Day as Old El Paso Celebrates Rare "Taco Totality" with Exclusive Merch and Tacos for Fans Nationwide
Businesswire· 2026-04-21 22:15
Cinco de Mayo and Taco Tuesday Fall on the Same Day as Old El Paso Celebrates Rare "Taco Totality" with Exclusive Merch and Tacos for Fans Nationwide Apr 21, 2026 10:15 AM Eastern Daylight Time Cinco de Mayo and Taco Tuesday Fall on the Same Day as Old El Paso Celebrates Rare "Taco Totality" with Exclusive Merch and Tacos for Fans Nationwide Share To help everyone make the most of the rare taco eclipse on May 5, Old El Paso is debuting limited-edition gear designed to enhance every bite and new Old El Paso ...
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
Globenewswire· 2026-04-21 22:15
DOYLESTOWN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea", or the "Company"), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today announced the acceptance of an abstract "Early results from the first-in-human phase 1 study of WEE1 inhibitor APR-1051 in patients with advanced solid tumors (ACESOT-1051)" at the 2026 American Society of Clinical Oncology ...